 | NeuroBo Pharmaceuticals, Inc. | |||
| NCM : NRBO || Location: United States | ||||
$3.02-0.1 (-3.21%) |
0.04 M | 2.99 - 3.19 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 0.062 M |
| March 15, 2024 | 0.068 M |
| Feb. 29, 2024 | 0.041 M |
| Feb. 15, 2024 | 0.132 M |
| Jan. 31, 2024 | 0.027 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.80 | -2.28 | -184.75% |
| 09/30/2023 | -0.87 | -0.72 | 17.54% |
| 06/30/2023 | -1.03 | -0.16 | 84.44% |
| 03/31/2023 | -5.14 | -0.77 | 85.09% |
| 12/31/2022 | -9.79 | -14.56 | -48.69% |
NRBO Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 4.906M | Shares Float | 4.714M |
| Short Float | 0.062M | Market Cap | 14.82M |
| Institution ownership | 1.37% | Insider ownership | 61.665% |
| Earnings Date | 05/10/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -2.46 | Forward EPS | -1.90 |